CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, July 29th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...